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INTRODUCTION
Academic detailing, an educational intervention 
programme, in which a trained healthcare profes-
sional visits clinicians in their offices to provide 
evidence-based information, has been used as a 
major tool to improve rational use of medicines 
since it was started for the first time in 1983 (1,2). 
The process involves face-to-face education of 
clinicians by trained academic detailers. The aca-
demic detailers are usually healthcare professionals, 
like pharmacists, clinicians, nurses, or any persons 
trained on the subject matter (1). Academic de-
tailing programmes have been particularly used 
for improving the knowledge of clinicians on par-
ticular topics, changing prescribing pattern of tar-
geted drugs to be consistent with medical evidence, 
providing medical care in cost-effective ways, or 
minimizing risks to patients due to wrong practice 
(3-6). A meta-analysis, including 69 studies involv-
ing more than 15,000 healthcare professionals, 
reported that academic detailing, as a single in-
tervention or in combination with other inter-
ventions, had relatively small but consistent and 
important influence on prescribing behaviour. The 
same study also suggested that effects of academic 
detailing on other types of professional perfor-
mance of healthcare providers varied from small 
to modest improvements; however, the authors 
were unable to quantify such variations (7). 
Academic detailing has been practised for many 
years in developed countries (2,8-10). However, 
the concept of academic detailing is still at prema-
ture phase in developing countries, like Nepal (11). 
There are very few studies on academic detailing 
from developing countries. Hence, our research was 
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Academic detailing is rarely practised in developing countries. A randomized control trial on healthcare 
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in the intervention group were adhering to the guidelines, which was significantly (p<0.05) greater than 
those in the control group (19.0%). Data also showed significant improvement in prescribing pattern of the 
participants in the intervention group compared to the control group. Therefore, academic detailing can be 
used for promoting adherence to treatment guidelines in developing countries, like Nepal.
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carried out in Banke district of Nepal to evaluate the 
impact of academic detailing programme on child-
hood diarrhoea management by primary health-
care providers. Prior to this research, a small pilot 
study was carried out on 10 healthcare profession-
als in the same district. The pilot study was done 
to ensure methodological validation, including 
training of academic detailers, data collectors, and 
simulated clients (12). This article aims to describe 
the feasibility of academic detailing in developing 
countries, like Nepal, by evaluating the outcome 
of the same programme in terms of (i) clinicians’ 
prescribing pattern, (ii) adherence to childhood 
diarrhoea treatment guidelines, and (iii) change in 
their prescription cost. The following hypotheses 
were set prior to this research:
(a) Academic detailing will significantly increase 
prescribing of the oral rehydration solutions 
and zinc for the treatment of diarrhoea without 
dehydration by primary healthcare providers in 
the intervention group compared to the control 
group.
(b) Academic detailing will significantly decrease 
the prescription of unnecessary medicines, 
like antimicrobials, medicines affecting gastric 
motility, vitamins, and enzyme preparations 
among participants in the intervention group 
to treat acute diarrhoea without dehydration 
compared to the control group.
(c) Academic detailing will significantly increase 
the compliance with WHO/UNICEF-endorsed 
“Diarrhoea treatment guidelines, including 
new recommendations for the use of ORS and 
zinc supplementation for clinic-based health-
care workers” among the primary healthcare 
providers in the intervention group compared 
to the control group.
MATERIALS AND METHODS
Study design
A randomized control trial on healthcare was con-
ducted to evaluate the impact of academic detail-
ing programme on the childhood diarrhoea man-
agement by primary healthcare providers in Banke 
district of Nepal. This study consisted of a phase of 
data collection prior to four different academic de-
tailing sessions and two phases of data collections 
after those academic detailing sessions. 
Study site and duration
The study was carried out from July 2009 to March 
2010 in Banke district of Nepal. Banke district lies 
in the Midwestern region of Nepal. It is a plain flat 
land adjacent to the Indian border. The health in-
stitutions in urban part of the district consist of a 
300-bed government hospital, two 100-bed private 
hospitals, a 150-bed nursing home, and an 850-bed 
tertiary-care teaching hospital whereas the rural 
part consists of primary healthcare centres, health 
posts, and sub-health posts. 
Both urban and rural parts of this district have 
private practitioners, especially those having their 
clinics inside some pharmacies. This district is 
known to be one of the susceptible districts for 
childhood diarrhoea, and the Ministry of Health 
of the Government of Nepal has started Control 
of Diarrhoeal Disease (CDD) programme under 
Community-based Management of Childhood Ill-
ness (CB-IMCI) project to combat the childhood 
diarrhoea in this district. Annual report published 
by the Department of Health Services, Ministry of 
Health, Government of Nepal, reported visit of a to-
tal of 4,662 diarrhoeal children (between 2 months 
and 5 years of age) in the government healthcare 
institutions of Banke district (13). 
Study population
The study population comprised healthcare pro-
viders in Banke district, who had legal right to 
prescribe medicines and were working in primary 
healthcare settings and pharmacies. They included 
persons with the qualification of health assistants 
(HAs), community medical assistants (CMAs), 
auxiliary health workers (AHWs), and assistant 
nursing midwives (ANMs). There were altogether 
255 eligible participants in Banke district but, after 
omitting those who did not give their consent, they 
were involved in pilot study of this research, and 
those who dropped out due to various reasons, 
only 209 participants were included in all analy-
ses in this research. The main reasons for drop-out 
were migration, unavailability of participants dur-
ing data collection, and changing and closing of 
their clinics. The details are shown in Figure 1.
Inclusion criteria
Healthcare providers working in the government 
sub-health posts (SHPs), health posts (HPs) and pri-
mary healthcare centres (PHCCs) were included in 
the study, and those eligible healthcare providers 
who were practising in a pharmacy registered with 
the Department of Drug Administration were also 
the part of the study.
Khanal S et al.Academic detailing programme for diarrhoea management in Nepal
Volume 31 | Number 2 | June 2013 233
Exclusion criteria
The study excluded the following individuals:
(a) People working in pharmacies but do not have 
legal right to prescribe the medicines
(b) Practitioners working in their home-based set-
ting (neither government institution nor regis-
tered pharmacies)
(c) People working in both private and gov-
ernment settings were taken as government 
practitioners only. The interventions were 
carried out in government setting, and data 
from them were also collected from the same 
setting
(d) Ten practitioners who were participants in the 
pilot study
(e) Subjects who were not interested and refused to 
participate in the study.
Study sample
Stratified randomized sampling was done. The 
population was divided into two different strata—
intervention and control group. The whole meth-
od of sampling is shown in Figure 1.
Method of randomization
In the case of government healthcare providers, the 
list of healthcare providers working in SHPs, HPs, 
and PHCs were obtained from the district public 
health office. The names given by the office were 
already assigned in a numerical order. All health 
workers having odd numbers were treated as inter-
vention group, and those with even numbers were 
treated as control group.
Similarly, the list of registered pharmacies within 
Banke district was obtained from the Department 
of Drug Administration, Mid-western Regional Of-
fice. The list contained the names of pharmacies 
and names of persons under whom the pharmacies 
were registered. The researchers took the list and 
conducted a cross-sectional survey to find out 
the eligible prescribers from the list. The names of 
the eligible prescribers were arranged in alphabeti-
cal order and were numbered. All the names falling 
under odd numbers were treated as intervention 
group and the remaining as control group.
Study tools
The following study tools were used for this part of 
the study:
Data-collection form to collect information on 
prescribed medicines
A form was developed to collect information on 
the names of medicines and total cost of medi-
cines prescribed to the simulated client at baseline, 
first, and second follow-up phase of the study.
Academic detailers
There were altogether two academic detailers. 
The first one was a pharmacist with the B.Pharm 
degree, and the second one was a medical officer 
with a graduate-level medical education (MBBS). 
Both the academic detailers were from the local 
place and were good in English, Nepalese, and 
local languages of the district. The first academ-
ic detailer was trained in KIST Medical College, 
Lalitpur, Nepal. KIST Medical College was the 
only medical college in Nepal conducting regular 
academic sessions to the clinicians working in the 
teaching hospital of the same college (14). The 
first academic detailer conducted the pilot study 
of this research and, using the experience gained, 
he trained the second academic detailer. Both the 
academic detailers provided demonstration detail-
ing on the given topic to various levels of health-
care providers and healthcare students before go-
ing to the field. 
Simulated clients
The simulated clients comprised community 
medical assistants as students. The observation 
technique for simulated clients was adopted from 
the method mentioned by Hardon et al. (15). The 
simulated clients were trained about the symp-
toms of acute diarrhoea without dehydration, 
and were sent with a child between ages of 3 
and 4 years to the healthcare providers to collect 
information on prescribed medicines. The child 
was also simulated; he did not have any diar-
rhoeal episodes. They were given data-collection 
form to collect information on prescribed medi-
cines and were asked to fill these in immediately 
after each visit.
Ethical considerations
Ethical approval was taken from the Institutional 
Review Board, Nepalgunj Medical College and 
Teaching Hospital prior to conducting the experi-
ment. Verbal consents were taken from all partici-
pants via telephone calls before starting the data 
collection. The participants were given the descrip-
tion about objective of the study; the participants 
were also told they would attend visit by a simu-
lated client three times during the study period. 
Confidentiality of the data was also assured to all 
the participants by using coding method to record 
their responses.
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Operational modality
The phases in the study were: collection of pre-
intervention data, intervention in the form of 
academic detailing and collection of post-inter-
vention data soon after four series of academic de-
tailing sessions, and post-intervention data collec-
tion once again after three months of wash period. 
The details of operational modality are shown in 
Figure 2.
Collection of baseline data
Baseline data on prescribing patterns in acute di-
arrhoea without dehydration were obtained by 
sending simulated clients. Then the medicines pre-
scribed were entered in the data-collection from.
Interventions
Intervention was carried out in the form of academ-
ic detailing. Four consecutive academic detailing 
sessions were conducted for the intervention group 
for three months with an interval of one month 
between sessions. The academic detailing sessions 
were conducted by trained academic detailers. Aca-
demic detailing sessions were conducted as per the 
technique suggested by Soumerai and Avorn (6). 
The process was slightly modified according to the 
local setting and expertise.
Intervention I
Academic detailer spent around 20 minutes with 
each prescriber in this intervention. The topic was 
Total number of eligible participants=255
Number of participants not giving consent=10
Total number of remaining participants=245
Number of government practitioners=79
Number of private practitioners=166
Number of participants available for main study=235
Number of government practitioners=74
Number of private practitioners=161
Total number of  
participants selected for 
pilot study=10
Intervention group (n=118)
Number of government practitioners=37
Number of private practitioners=81
Control group (n=117)
Number of government practitioners=37
Number of private practitioners=80
Total number of 
dropouts=9
Total number of 
dropouts=9
Final intervention group (n=109)
Number of government practitioners=34
Number of private practitioners=75
Final control group (n=100)
Number of government practitioners=29
Number of private practitioners=71
Figure 1. Sampling method (N=209)
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“Clinical management of diarrhoea in children” 
based on the WHO/UNICEF recommendation. The 
emphasis was on promoting the prescription of 
ORS and zinc to the diarrhoeal child. The interven-
tion was also intended to decrease the use of anti-
protozoals, antimicrobials, medicines acting on GI 
motility, use of vitamins and enzyme preparations 
in cases of acute diarrhoea. The session detailed the 
dosage regimens of ORS and zinc at normal dose—
the situation when patients should receive fluid via 
intravenous and nasogastric route. 
Intervention II
Academic detailer spent around 15 minutes with 
each participant. The topic was “Home-based 
treatment of childhood diarrhoea” based on the 
WHO/UNICEF recommendation. The participants 
were trained regarding home-based alternatives to 
ORS, and also about the recommended foods and 
contraindicated drinks during this intervention. 
Importance of breastfeeding during diarrhoea was 
also mentioned. Finally, participants were told to 
counsel caretakers of every participants regarding 
home-based treatment in childhood diarrhoea.
Intervention III
This was done one month after Intervention II. 
Academic detailer spent around 15 minutes with 
each prescriber. The topic was “Evidence-based 
medicines for diarrhoea management in children” 
based on our scientific literature survey. Various 
sources of literature were surveyed to find out the 
importance of ORS and zinc in childhood diar-
rhoea; literature regarding non-evidence-based use 
of other medicines during diarrhoea was also col-
lected to develop the intervention tool. With the 
help of that intervention tool, real scientific reason 
behind prescribing ORS and zinc was discussed 
with participants. They were also told about the 
reason why antiamoebics, antimicrobials, medi-
cines affecting GI motility, multivitamins, and en-
zyme preparations may not be necessary in most 
diarrhoeal cases. Data on mortality and morbidity 
due to childhood diarrhoea was also presented to 
them to sensitize them regarding childhood diar-
rhoeal problem.
Intervention IV
This was done one month after Intervention III, 
and the academic detailer spent around 10 minutes 
with each prescriber. The topic was based upon the 
summary of all three previous interventions. All the 
findings from Intervention I, Intervention II, and 
Intervention III were summarized. The key points 
from the previous interventions were focused.
Collection of post-intervention data
Post-intervention data were collected in two phas-
es—first follow-up and second follow-up. The first 
follow-up data were collected 10-15 days after the 
last intervention (Intervention IV). Data on pre-
scribing patterns in acute diarrhoea were collected 
with the help of simulated clients. Medicines pre-
scribed to the simulated clients were entered in the 
data-collection form. Data on the second follow-
up were collected three months after the collection 
of the first follow-up data to find out sustainability 
of the impact of intervention. The type of data 
collected and tools and method used were similar 
to those used for baseline and the first follow-up. 
Evaluation of adherence to diarrhoea  
treatment guidelines
Simulated clients used in the study were trained on 
the symptoms of acute diarrhoea without dehydra-
tion. Only the participants prescribing evidence-
based medicines were considered to be adherent 
to diarrhoea treatment guidelines. The evidence-
based regimen for this condition consisted of only 
ORS and zinc supplementation. The prescription 
containing more than these two drugs was consid-
ered non-evidence-based. The prescriptions con-
taining either ORS or zinc were also not considered 
evidence-based prescription.
Method of data analyses
Microsoft Excel 2003 and Statistical Package for So-
cial Sciences (SPSS) for Windows (version 16) were 
used for statistical analyses. Frequency, mean, stan-
dard deviation, median, and interquartile range 
were used for descriptive purposes. The normality 
of the data was calculated by Kolmogorov-Smirnov 
test and was found to be non-linear or non-normal. 
Therefore, non-parametric tests, like chi-square test, 
Mann-Whitney U-test and Friedman test were used 
throughout the study where appropriate. A priori 
significant level of 0.05 was used in all analyses.
RESULTS
Demography of the participants
From among all participants, 209 were included 
in the analytical part of the study. The mean±SD 
age of the participants was 34.1±8.3 years. The me-
dian age of participants was 32 years [Interquartile 
range (IQR)=26-32 years]. The mean and median of 
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the length of experience in treating patients were 
7.3±3.3 and 8 years respectively (IQR=4-13 years). 
The control group and the intervention group of 
participants were not significantly different in terms 
of gender, age, type of organization, qualification, 
experience, and number of daily patient-visits. De-
tails on demography are illustrated in Table 1. 
Prescribing pattern of the participants
The baseline data revealed under-prescription of 
ORS and zinc by the participants of the study. At 
baseline, there was no significant difference be-
tween the control and the intervention group in 
terms of prescribing ORS and zinc. However, data 
from the first follow-up and second follow-up re-
vealed that there was significant increase in the 
prescription of ORS and zinc by participants in the 
intervention group compared to the control group. 
Antimicrobials, like metronidazole, fixed-dose 
combination of metronidazole and diloxanide fu-
roate, ciprofloxacin, norfloxacin, and nalidixic acid 
were prescribed at baseline by some participants. 
After intervention, there was a marked decrease in 
the number of participants prescribing metronida-
zole, fixed-dose combination of metronidazole and 
diloxanide furoate. However, there was no signifi-
cant difference between the control and the inter-
vention group in terms of prescribing ciprofloxa-
cin, norfloxacin, and nalidixic acid. Data from the 
study also revealed a reduction in the prescription 
of multivitamins and enzyme preparations by the 
participants in the intervention group compared to 
the control group during the first and the second 
follow-up. Another analysis was done to see the 
changes in the prescribing pattern among partici-
pants from baseline to the first and the second fol-
low-up. Data revealed that there was a significant 
increase in the number of participants prescribing 
ORS among both control and intervention group 
from baseline to the first and the second follow-up. 
Similarly, there was also an increase in the number 
of participants prescribing zinc by participants of 
the intervention group from baseline to the first 
and the second follow-up. However, such chang-
es were not observed among participants in the 
control group. A marked decrease in the num-
ber of participants prescribing metronidazole 
among both control and intervention group was 
observed during the first and the second follow-
up compared to baseline among both control and 
intervention group. In the case of fixed-dose com-
bination of metronidazole and diloxanide furoate, 
multivitamins, and enzyme preparations, the 
marked decreased was only seen among partici-
Collection of baseline data
•	 Use	of	simulated	clients
•	 Information	on	prescribed	medicines	was	
collected
Intervention I
•	 Length:	Approximately	20	minutes
•	 Topic:	‘Clinical	management	of	diarrhoea	
in children’ based on WHO/UNICEF rec-
ommendation
Intervention II
•	 Length:	Approximately	15	minutes
•	 Topic:	‘Home-based	treatment	on	child-
hood diarrhoea’ based on WHO/UNICEF 
recommendation
Intervention III
•	 Length:	Approximately	15	minutes
•	 Topic:	‘Evidence-based	medicine	for	 
diarrhoea management in children’ 
based on scientific literature survey
Intervention IV
•	 Length:	Approximately	10	minutes
•	 Topic:	 ‘Summary:	 childhood	 diarrhoea	
management’ based on the summary of 
three previous sessions
Collection of post-intervention data
•	 Use	of	simulated	clients
•	 Information	on	prescribed	medicines	was	
collected
Collection of post-intervention data
•	 Use	of	simulated	clients
•	 Information	on	prescribed	medicines	was	
collected
1-2
Weeks
1
Month
1
Month
1
Month
1-2
Weeks
3
Months
Figure 2. Flowchart showing operational modal-
ity of research
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the second follow-up phase of the study. Details of 
the change in the prescribing pattern among par-
ticipants from baseline to the first and the second 
follow-up phase of the study for both control and 
intervention group are given in Table 2.
Percentage of participants adhering to the  
diarrhoea treatment guidelines
At baseline, less than 10% of the participants were 
adhering to the diarrhoea treatment guidelines, 
and there was no significant difference between 
the control and the intervention group in terms 
of percentage of participants adhering to the diar-
rhoea treatment guidelines. However, there was a 
significant increase in the number of participants 
adhering to the diarrhoea treatment guidelines 
among the intervention group compared to the 
control group. There was a remarkable increase in 
the number of participants among both control 
and intervention group adhering to the diarrhoea 
treatment guidelines from baseline to the first and 
the second follow-up phase of the study. Data on 
change in the percentage of participants adhering 
to the diarrhoea treatment guidelines from baseline 
to the first and the second follow-up phase of the 
study are given in Table 3.
Cost of medicines prescribed by participants 
working in private setting
The cost of medicines prescribed by participants 
working in private setting was analyzed at baseline, 
the first follow-up, and the second follow-up phase 
of the study. Among 146 private practitioners par-
ticipating in this study, 71 were in the control group 
and 75 in the intervention group. At baseline, there 
was no significant difference between the control 
and the intervention group in terms of prescription 
cost. However, after intervention during the first 
and the second follow-up, there was a significant 
reduction in the prescription cost in the interven-
tion group compared to the control group. Data 
also showed that there was a statistically-significant 
decrease in the cost of medicines prescribed by par-
ticipants in the intervention group from baseline 
to the first and the second follow-up phase of the 
study. However, such changes were not seen among 
participants in the control group. Data on changes 
on cost of the prescribed medicines at various stages 
of the study are presented in Table 4.
DISCUSSION
Childhood diarrhoea is one of the major causes of 
mortality and morbidity in Nepal (16). Studies done 
in many countries reported diarrhoea manage-
Table 1. Demographic characteristics of  
participants 
Characteristics
Number of participants
Control 
group 
(n=100)
Inter-
vention 
group 
(n=109)
p 
value
Gender
Male 66 72 0.993
Female 34 37
Age
21-<31 years 49 45 0.572
31-<41 years 38 46
41-50 years 11 13
>50 years 2 3
Type of organization
Government 29 34 0.730
Private 71 75
Location
Urban 48 53 0.928
Rural 52 56
Qualification
AHW 44 46 0.847
CMA 6 6
HA 36 45
NM 14 12
Experience (in years) 
<6 years 31 35 0.082
6-<11 years 40 37
11-<16 years 11 22
16-20 years 11 8
>20 years 7 7
Number of daily patient-visits
<11 6 4 0.915
11-20 13 12
21-30 35 43
31-40 13 17
41-50 11 10
>50 22 23
p value (two-sided) was calculated by chi-square test; 
AHW=Auxiliary health worker; ANM=Auxiliary 
nurse-midwife CMA=Community medical assis-
tant; HA=Health assistant
pants in the intervention group from baseline to 
the first and the second follow-up. However, such 
changes were not seen among participants in the 
control group. There was no marked change in the 
number of participants prescribing ciprofloxacin, 
norfloxacin, and nalidixic acid in both control and 
intervention group from baseline to the first and 
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ment as one of the areas where we can find many 
cases of non-evidence-based prescriptions, includ-
ing unnecessary prescription of antimicrobials, 
medicines affecting gastric motility, multivitamins, 
and enzyme preparations (17-19). The magnitude 
of non-evidence-based prescription will be much 
greater in the presence of other confounding fac-
tors that negatively influence prescribing patterns. 
A survey done in six major cities of Nepal reported 
that the pharmacists working in the community 
settings lacked proper books and had limited ac-
cess to reliable unbiased source of information 
on drugs (20,21). An article suggested that, with 
increase in the number of pharmaceutical compa-
nies, clinicians in Nepal are in high risk of receiv-
ing biased information from their pharmaceutical 
representatives (22). Limited access to the unbiased 
source of information on medicines, coupled with 
the incidence of receiving biased information from 
the pharmaceutical companies, may put primary 
healthcare providers in Banke district at higher risk 
of prescribing wrongly. Therefore, four academic 
detailing sessions on childhood diarrhoea manage-
ment were conducted for the primary healthcare 
providers in Banke district of Nepal. Of 209 partici-
pants, academic detailing sessions were provided 
to 109 participants (intervention group) while 100 
participants (control group) were not provided 
with academic detailing sessions. The demographic 
data showed that participants in the control and 
intervention groups were similar in terms of gender 
and age distribution. They were also homogeneous 
in terms of the type of organization where they 
were working (private or government), qualifica-
tion, and the estimated number of patients visiting 
their clinic daily.
Oral rehydration solution (ORS) is considered 
the first-line treatment for any diarrhoeal child 
(23). However, our finding suggested that only 
about half of the participants prescribed ORS to 
the simulated clients, indicating that there was 
under-prescription of ORS among the primary 
healthcare providers of Banke district of Nepal. 
Finding of the under-use of ORS was in contrast to 
annual health report of Nepal, which highlighted 
99% use of ORS by diarrhoeal children in Banke 
district of Nepal (16). However, after four succes-
sive evidence-based academic detailing sessions on 
childhood diarrhoea and its management, there 
was a marked increase in prescribing ORS among 
participants in the intervention group compared to 
the control group during the first and the second 
follow-up phase of the study. These improvements 
were higher in magnitude compared to findings 
Table 2. Change in prescribing pattern among par-
ticipants at various phases of the study
Treatment 
Percentage of 
participants
p valueControl 
group 
(n=100)
Inter-
vention 
group 
(n=109)
ORS
Baseline 60 57.8 0.747
First follow-up 72 91.7 <0.001*
Second follow-up
p value
79
<0.001*
95.4
<0.001* <0.001*
Zinc
Baseline 32 31.2 0.900
First follow-up 62 87.2 <0.001*
Second follow-up
p value
76
<0.004*
96.7
<0.001* <0.001*
Metronidazole
Baseline 56.0 54.1 0.786
First follow-up 44.0 7.3 <0.001*
Second follow-up
p value
20.0
0.014*
4.6
<0.001*
0.006*
Metronidazole+Diloxanide Furoate
Combination
Baseline 18.0 19.2 0.814
First follow-up 20.0 6.4 0.003*
Second follow-up
p value
18.0
0.916
6.4
0.002* <0.001*
Ciprofloxacin
Baseline 6.0 1.2 0.117
First follow-up 5.0 1.8 0.204
Second follow-up
p value
3.0
0.248
3.7
0.115 0.788
Norfloxacin
Baseline 3.0 1.8 0.582
First follow-up 2.0 1.8 0.972
Second follow-up
p value
3.0
0.346
4.6
0.114 0.550
Nalidixic acid
Baseline 3.0 1.8 0.582
First follow-up 5.0 1.8 0.204
Second follow-up
p value
5.0
0.548
1.8
0.692 0.204
Multivitamins
Baseline 19.0 19.3 0.961
First follow-up 16.0 5.5 0.014*
Second follow-up
p value
21.0
0659
6.4
0.001* 0.002*
Enzyme preparations
Baseline 11.0 12.8 0.682
First follow-up 14.0 5.5 0.037*
Second follow-up
p value
16.0
0.810
4.6
0.046* 0.032*
p value (two-sided) was calculated by chi-square 
test;*p value significant at α=0.05
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of a meta-analysis on academic detailing (7). This 
improvement can be attributed to the format of 
this academic detailing programme; four consecu-
tive academic detailing sessions on the same topic 
were done, which was uncommon with regard 
to published studies (7). Similarly, other studies 
conducted in Kenya and Indonesia also reported 
a significant increase in the use of ORS following 
academic detailing sessions for pharmacists (4). 
A meta-analysis showed that the incidence, severity, 
and episodes of diarrhoea are significantly reduced 
following administration of zinc supplementation 
with ORS (24). Therefore, World Health Organiza-
tion and United Nations Children’s Fund jointly 
recommended ORS and zinc therapy to manage 
diarrhoea in children (23). However, baseline data 
of this study suggested that a very few participants 
prescribed zinc to their simulated clients. This can 
be attributed to the fact that zinc was just newly 
introduced in Nepalese market (25). However, after 
the intervention, there was a statistically-significant 
increase in the number of participants prescribing 
zinc among both control and intervention group. 
This might be due to the nationwide campaign to 
promote the use of ORS and zinc (25). However, a 
significant difference between the control and the 
intervention group during both first and second 
follow-up shows that participants in the interven-
tion group were prescribing zinc more compared 
to the control group. This shows that academic 
detailing can also be used as a tool to provide in-
formation on new medicine to the clinicians. The 
effectiveness of academic detailing, as a possible 
source of information on medicine in Nepal, has 
been already discussed elsewhere (26). 
The baseline data of the study also showed prescrip-
tions of a large number of other medicines, like-
metronidazole and fixed-dose combination of met-
ronidazole and diloxanide furoate to the simulated 
clients having acute diarrhoea without dehydration. 
Such antiprotozoals are not required for the pa-
tients unless the diarrhoea is infectious (23). Many 
studies reported the intensive use of antimicrobi-
als and other unnecessary medicines even during 
Table 3. Change in percentage of participants adhering to the diarrhoea treatment guidelines during 
different phases of the study
Phase 
Percentage of participants
p valueControl group  
(n=100)
Intervention group 
(n=109)
Baseline 6.0 8.3 0.528
First follow-up 16.0 65.1 <0.001*
Second follow-up 19.0 69.7 <0.001*
p value 0.011* <0.001*
p value (two-sided) was calculated by chi-square test; *p value significant at α=0.05
Table 4. Change in the cost prescribed medicines at various stages of the study
Phase
Total cost of prescription in Nepalese Rupees
p valueControl group  
(n=71)
Intervention
group (n=75)
Baseline
Mean±SD 65.6±33.0 67.1±37.2
0.994
Median (IQR) 68.0 (40-88) 64.0 (38-89)
First follow-up
Mean±SD 64.9±33.0 54.7±29.6
0.034*
Median (IQR) 65.0 (38-90) 44.0 (38-66.5)
Second follow-up
Mean±SD 65.8±33.0 52.6±28.5
0.007*Median (IQR)
p value
62 .0 (38-88)
0.894
44 0 (38-58)
0.098*
p value (two-sided) was calculated by Mann-Whitney U-test in horizontal axis and by Friedman test in 
vertical axis of this table; *p value significant at α=0.05
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non-infective diarrhoea (17,19,27,28). However, in 
this study, only a few of the participants prescribed 
such antimicrobials. Multivitamins supplementa-
tion and enzyme preparations are usually advised 
in case of malnutrition (28). During simple acute di-
arrhoea, the prescription of such preparations only 
increases the economic burden for the patients (24). 
The academic detailing significantly improved the 
prescribing pattern of the participants. There was a 
significant reduction in the number of participants 
prescribing different antimicrobials, multivitamins, 
and enzyme preparations among the intervention 
group compared to the control group. For increase 
in the number of participants prescribing useful 
medicines and decrease in the number of partici-
pants prescribing unnecessary medicines, it is evi-
dent that academic detailing can promote rational 
prescribing, justifying the first two hypotheses of 
this study. The number of participants adhering to 
the diarrhoea treatment guidelines also significantly 
increased among the intervention group compared 
to those in the control group during the first and 
the second follow-up phase of the study, which was 
in agreement with the third hypotheses set prior to 
the study. After academic detailing, there was also 
a significant decrease in the cost of medicines pre-
scribed to simulated clients by participants in the 
intervention group compared to participants in the 
control group. These all suggested that academic 
detailing was feasible in resource-limited setting 
and was able to improve the prescribing behaviour 
of the participants and their adherence to the child-
hood diarrhoea treatment guidelines, and decrease 
the cost of medicines prescribed to the patients. 
These findings were close to the findings of previ-
ous studies that evaluated the impact of academic 
detailing in developed countries (1,29-32). There-
fore, academic detailing can even be practised in 
resource-limited countries, like Nepal. The sessions 
on information regarding newer medicines in the 
market, reporting of adverse drug reaction, rational-
ity of fixed-dose combination of drugs, rational use 
of antimicrobials, and proper use of non-steroidal 
anti-inflammatory drugs, may be some important 
areas for academic detailing. Academic detailing 
has an ample scope in Nepal and can contribute a 
lot to the clinicians who have very limited access to 
the source of unbiased information on medicines 
(11,26). 
Limitations 
This study was done on the primary healthcare pro-
viders in Banke district of Nepal. It may be difficult 
to generalize these findings for other districts of 
Nepal. The primary healthcare providers working 
on their home-based settings (neither government 
centre nor private clinic) were not included in this 
study. In analyses, drop-out cases were not consid-
ered. Prescribing behaviour was difficult to evaluate 
with the simulated clients; so, only prescribing pat-
terns were studied. The study did not evaluate the 
effect of confounding factors, like role of media, 
pharmaceutical representatives, and other forms of 
training which participants might have taken dur-
ing study period. In the economic evaluation part 
of the study, only private participants were con-
sidered because medicines at government primary 
healthcare facilities are provided free of charge to 
the patients. This study could not evaluate the ac-
tual economic benefit of academic detailing; it did 
not consider the investment in academic detailers, 
academic detailing tools, travel expenses, and other 
miscellaneous expenses. 
Conclusions
The present study successfully evaluated the impact 
of academic detailing programme on prescribing 
pattern, adherence of participants to childhood di-
arrhoea treatment guidelines and prescription cost 
among the primary healthcare providers in Banke 
district of Nepal. Baseline data showed under-use of 
ORS and zinc, unnecessary prescribing of some an-
timicrobials, vitamins, and enzyme preparations. It 
showed that participants in the control group ad-
hered to the diarrhoea treatment guidelines. How-
ever, academic detailing increased the use of ORS 
and zinc and decreased the prescribing of unneces-
sary antimicrobials, vitamins, and enzyme prepara-
tions. Academic detailing also decreased the cost of 
prescription for the patients.
Academic detailing can be used as a good means of 
information on medicines for the primary health-
care providers in developing countries, like Nepal. 
The programme can successfully improve the pre-
scribing pattern of the primary healthcare provid-
ers. Although this study shows less magnitude of 
cost reduction for treatment, it may be very signifi-
cant for the healthcare financing bodies at policy 
level. Therefore, this type of programme should 
be taken up by universities, social welfare organi-
zations, professional societies, policy-makers, and 
relevant stakeholders in order to improve rational 
use of medicines in the community.
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